142 related articles for article (PubMed ID: 8791967)
1. A trial of lansoprazole in refractory gastric ulcer.
van Rensburg CJ; Louw JA; Girdwood AH; Simjee AE; Marks IN
Aliment Pharmacol Ther; 1996 Jun; 10(3):381-6. PubMed ID: 8791967
[TBL] [Abstract][Full Text] [Related]
2. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
3. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
Spencer CM; Faulds D
Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
[TBL] [Abstract][Full Text] [Related]
4. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
[TBL] [Abstract][Full Text] [Related]
5. Rapid healing of gastric ulcers with lansoprazole.
Bardhan KD; Ahlberg J; Hislop WS; Lindholmer C; Long RG; Morgan AG; Sjostedt S; Smith PM; Stig R; Wormsley KG
Aliment Pharmacol Ther; 1994 Apr; 8(2):215-20. PubMed ID: 8038354
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole: an update of its place in the management of acid-related disorders.
Matheson AJ; Jarvis B
Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
Aoyama N; Kinoshita Y; Misaki F; Himeno S; Kasuga M; Chiba T
J Clin Gastroenterol; 1995; 20 Suppl 2():S86-9. PubMed ID: 7594351
[TBL] [Abstract][Full Text] [Related]
9. Effect of lansoprazole on peptic ulcers.
Ohashi T; Sakata J; Haraguchi Y; Eto T
J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350
[TBL] [Abstract][Full Text] [Related]
10. Effects of lansoprazole on gastric ulcer healing and mucin content.
Komuro Y; Ishii K; Miyake Y; Tanabe S; Oida M; Saigenji K
J Clin Gastroenterol; 1995; 20 Suppl 2():S47-51. PubMed ID: 7594339
[TBL] [Abstract][Full Text] [Related]
11. Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat.
Kuwayama H; Matsuo Y; Eastwood GL
Am J Med; 1991 Aug; 91(2A):15S-19S. PubMed ID: 1882902
[TBL] [Abstract][Full Text] [Related]
12. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
Barradell LB; Faulds D; McTavish D
Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
[TBL] [Abstract][Full Text] [Related]
13. Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.
Kaneko E; Hoshihara Y; Sakaki N; Harasawa S; Ashida K; Asaka M; Asaki S; Nakamura T; Kobayashi K; Kajiyama G; Ogawa N; Yao T; Muto Y; Nakazawa S; Takemoto T
J Gastroenterol; 2000; 35(11):824-31. PubMed ID: 11085491
[TBL] [Abstract][Full Text] [Related]
14. A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group.
Avner DL; Dorsch ER; Jennings DE; Greski-Rose PA
Aliment Pharmacol Ther; 1995 Oct; 9(5):521-8. PubMed ID: 8580272
[TBL] [Abstract][Full Text] [Related]
15. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole.
Londong W; Barth H; Dammann HG; Hengels KJ; Kleinert R; Müller P; Rohde H; Simon B
Aliment Pharmacol Ther; 1991 Jun; 5(3):245-54. PubMed ID: 1888824
[TBL] [Abstract][Full Text] [Related]
16. [Lansoprazole--profile of a new proton pump inhibitor].
Seifert E
Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H
J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
[TBL] [Abstract][Full Text] [Related]
18. Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors.
Tsukamoto Y; Goto H; Hase S; Niwa Y; Arisawa T; Hayakawa T; Yoshikane H
J Clin Gastroenterol; 1995; 20 Suppl 2():S40-3. PubMed ID: 7594337
[TBL] [Abstract][Full Text] [Related]
19. Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial.
Michel P; Lemaire M; Colin R; Bommelaer G; Rambaud JC; Dupas JL; Bigard MA; Verwaerd JC
Aliment Pharmacol Ther; 1994 Feb; 8(1):119-22. PubMed ID: 8186337
[TBL] [Abstract][Full Text] [Related]
20. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
